While standard receptacles typically use three wires -- hot, neutral and ground -- you'll occasionally find 2-prong outlets in older homes. Since this type of outlet lacks a ground connection, the ...

The deadline to file a claim for money from the $177 million AT&T class action settlement is coming up. AT&T agreed to the settlement to resolve a lawsuit that accused it of failing to protect ...

In November 2024, AT&T (T) agreed to buy some wireless spectrum licenses from US Cellular in a $1.02 billion deal that requires approval from the Federal Communications Commission. The FCC under ...

The deadline to file a claim and potentially get money as part of a $177 million AT&T settlement is approaching. The settlement is in connection with two separate data breaches that AT&T announced ...

Nearly a year and a half after AT&T's first data breach was announced, a $177 million legal settlement could offer each eligible customer up to $7,500 in compensation. Still haven't filed a claim?

We have everything you need to know about AT&T's network, along with the top phones we've tested for it. I’m one of PCMag’s mobile writers. That means I check out phones, hotspots, and mobile networks ...

AT&T's $177 million settlement is for data breaches in 2019 and 2024. Claim up to $5,000 (first breach) and $2,500 (Snowflake hack), or both. File your claim by Dec. 18, 2025, either online or by mail ...

If you were a customer of AT&T in 2019 or 2024, you could be eligible to receive up to $7,500 in compensation for two data breaches. Peter is a writer and editor for the CNET How-To team. He has been ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Were you caught up in either of the two AT&T data breaches from 2019 or 2024? If so, you might be eligible for part of a $177 million settlement. According to court documents, the settlement fund ...

CD27 is a key T-cell costimulatory receptor, but efforts to target CD27 have been limited by the poor clinical efficacy of first-generation anti-CD27 antibodies. The authors here engineer ...